![]() |
|
|
Vol. 29, Issue 11, 1377-1388, November 2001
Department of Medicinal Chemistry, University of Washington,
Seattle, Washington
A series of 1"-mono-, di-, and trifluorinated analogs of
propranolol and related steric congeners was prepared, and their metabolism was examined in recombinant-expressed CYP2D6. The structural changes in this series of compounds, principally added fluorines and
methyl groups in the 1"-position of the N-isopropyl
group, provided compounds that varied in pKa
by more than 5 log units and also varied in lipophilicity and in steric
size. Products of both aromatic hydroxylation and
N-dealkylation were observed in the metabolic
experiments. The regiochemistry of aromatic hydroxylation at the 4'-
and 5'-positions was assigned based on high-pressure liquid
chromatography, fluorescence, and mass spectral characteristics of the
products and standards. Correlations of the metabolic kinetic parameters Km and catalytic efficiency
(kcat/Km) with
substituent parameters of the added groups showed that increased
basicity (higher pKa values) was associated
with increased enzyme affinity (low Km
values) and increased catalytic efficiency. More basic methyl-substituted compounds showed higher affinities for CYP2D6 than
the structurally analogous less basic fluorinated congeners, indicating
the decrease in affinity of the fluorinated compounds was not due to
the size of the N-alkyl substituent. Correlations with
log D reflected the degree of ionization and showed that the less
lipophilic substrates (more basic compounds) had higher affinity for
CYP2D6. These results are consistent with the proposal in the
literature that ion pairing of the protonated amine of the substrate
with Asp301 in the active site of CYP2D6 is very important to substrate affinity.
This article has been cited by other articles:
![]() |
L. K. Chico, H. A. Behanna, W. Hu, G. Zhong, S. M. Roy, and D. M. Watterson Molecular Properties and CYP2D6 Substrates: Central Nervous System Therapeutics Case Study and Pattern Analysis of a Substrate Database Drug Metab. Dispos., November 1, 2009; 37(11): 2204 - 2211. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bonn, C. M. Masimirembwa, Y. Aristei, and I. Zamora The Molecular Basis of CYP2D6-Mediated N-Dealkylation: Balance between Metabolic Clearance Routes and Enzyme Inhibition Drug Metab. Dispos., November 1, 2008; 36(11): 2199 - 2210. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Kalgutkar, S. Zhou, O. A. Fahmi, and T. J. Taylor Influence of Lipophilicity on the Interactions of N-Alkyl-4-phenyl-1,2,3,6-tetrahydropyridines and Their Positively Charged N-Alkyl-4-phenylpyridinium Metabolites with Cytochrome P450 2D6 Drug Metab. Dispos., May 1, 2003; 31(5): 596 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Upthagrove and W. L. Nelson Importance of Amine pKa and Distribution Coefficient in the Metabolism of Fluorinated Propranolol Analogs: Metabolism by CYP1A2 Drug Metab. Dispos., November 1, 2001; 29(11): 1389 - 1395. [Abstract] [Full Text] [PDF] |
||||